Sigma-Tau developed Cystaran in partnership with the National Institutes of Health and in cooperation with the Cystinosis Foundation, the Cystinosis Research Foundation and the Cystinosis Research Network

The Pfenex project has been funded by the National Institutes of Health

Benitec Biopharma Ltd., of Sydney, Australia, said its subsidiary, Tacere Therapeutics Inc., submitted an application to the National Institutes of Health's Recombinant DNA Advisory Committee (RAC), comprising the full clinical trial protocol for its ddRNAi-based therapeutic, TT-034, in hepatitis C virus infection, as well as safety and toxicology data

A recent National Institutes of Health meta-analysis of 21 studies involving more than 400,000 patients reported that transfusion of older vs

Cell Therapeutics Inc., of Seattle, said the National Institute for Health and Care Excellence (NICE), a nondepartmental public body of the Department of Health in the UK, issued draft guidance on Pixuvri (pixantrone) as a monotherapy for the treatment of adults with multiply relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma, recommending against funding of Pixuvri by the UK's National Health Service and requesting that consultees, including the company, health care professionals

To help launch the initiative, the president's 2014 budget will call for about $100 million in funding from the National Institutes of Health, the Defense Advanced Research Projects Agency and the National Science Foundation

Actinobac Biomed Inc., of New Brunswick, N.J., said it received a $202,000 Small Business Technology Transfer grant from the National Institutes of Health to study its drug candidate, Leukothera, in B-cell lymphomas

InterMune Inc., of Brisbane, Calif., received a positive final appraisal determination from the UK's National Institute for Health and Clinical Excellence for Esbriet (pirfenidone) as a treatment of mild to moderate idiopathic pulmonary fibrosis (IPF

Milo Biotechnology LLC, of Cleveland, received a $300,000 Phase I Small Business Innovation Research grant from the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases

Epic Sciences Inc., of San Diego, received a Phase II SBIR award from the National Cancer Institute and National Institutes of Health to identify and characterize circulating tumor cells in lung cancer patients

Alimera Sciences Inc., of Atlanta, and pSivida Corp., of Watertown, Mass., said the UK's National Institute for Health and Clinical Excellence (NICE) published final guidance indicating Iluvien (fluocinolone acetonide intravitreal implant) is not cost effective for treating chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies

Reset Therapeutics, of Burlingame, Calif., said the National Institutes of Health awarded a five-year cooperative agreement to develop a drug for narcolepsy

pSivida Corp., of Watertown, Mass., said the UK's National Institute for Health and Clinical Excellence (NICE) issued a final draft guidance indicating that Iluvien is not recommended for the treatment of chronic diabetic macular edema (DME), which insufficiently responds to available therapies

Bavarian Nordic A/S, of Kvistgard, Denmark, said the Department of Homeland Security (DHS) Science and Technology Directorate and the National Institutes of Health (NIH) awarded the company two new contracts valued at up to $18.9 million for the development of recombinant modified vaccinia virus Ankara-based vaccines, building on the company's MVA-BN platform

The peer-reviewed grant will support a Phase II investigation and first approved National Institutes of Health study of the company's VSELs in humans as a potential treatment for periodontitis

Bavarian Nordic A/S, of Kvistgard, Denmark, said the Department of Homeland Security (DHS) Science and Technology Directorate and the National Institutes of Health (NIH) awarded the company two new contracts valued at up to $18.9 million for the development of recombinant modified vaccinia virus Ankara-based vaccines, building on the company's MVA-BN platform

Factor Bioscience, of Boston, said it was awarded two Small Business Innovation Research grants through the National Institutes of Health's Office of the Director and the National Center for Advancing Translational Sciences to help accelerate the development of new treatments for Alzheimer's disease (AD

Richard J. Klein filed the lawsuit three years ago, alleging that Omeros falsified timekeeping records on a National Institutes of Health research grant

The Drug Development Office at London-based Cancer Research UK is partnering with the UK's National Institute for Health Research and Imperial College London to conduct a Phase IIa trial of AZD4547, from AstraZeneca plc, of London, in combination with existing therapies, to treat postmenopausal women with metastatic breast cancer who are not responding to standard treatment